Who is sponsoring NCT05431036?

NCT05431036 is sponsored by Assiut University.

What drugs are being tested in NCT05431036?

Interventions in NCT05431036: transthoracic ultrasonography.

What condition does NCT05431036 study?

NCT05431036 studies Weaning Failure.

Is NCT05431036 still recruiting?

NCT05431036 is currently status unknown. Last updated 4 October 2022.

Last reviewed 2022-10-04 · How we verify

NCT05431036

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Combined Model in Predicting Weaning Outcome in Critically Ill Patients.

Status unknown Last updated 4 October 2022

What this trial tests

trial testing transthoracic ultrasonography in Weaning Failure in 100 participants. Status unknown.

Timeline

1 November 2022

Primary endpoint
1 June 2024

1 September 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 November 2022
Primary completion	1 June 2024
Estimated completion	1 September 2024

Drugs / interventions tested

transthoracic ultrasonography

Conditions studied

Weaning Failure — all drugs for Weaning Failure →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Weaning Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of our study is to assess lung aeration and diaphragmatic indices by transthoracic ultrasonography in patients ready to be weaned from mechanical ventilation as predictors of weaning success

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Weaning Failure

Currently open trials in the same condition.

NCT07105202 — Shorter Weaning From Invasive Ventilation With Levosimendan · Phase 4 · recruiting
NCT07003672 — Role of Regional Lung Compliance and Dynamic Transpulmonary Driving Pressure in the Liberation Difficulty in Tracheostom · recruiting
NCT06683781 — Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients · recruiting
NCT06754670 — Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning · recruiting
NCT06592144 — TESTO-TRIAL: Use of Testosterone in Critically Ill Patients · Phase 4 · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05431036 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 4 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05431036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing